Core Viewpoint - The company, Hangzhou Fulai Ant Technology Co., Ltd., has announced the use of part of its idle raised funds for cash management, with a maximum amount of RMB 86 million allocated for low-risk investment products to enhance fund utilization efficiency and generate financial returns for the company and its shareholders [2][13]. Summary by Sections Cash Management Overview - The purpose of cash management is to improve fund utilization efficiency and generate financial returns for the company and its shareholders [3]. - The investment amount for this cash management initiative is RMB 55 million [4]. - The funds used for purchasing financial products are sourced from the company's idle raised funds [4]. Fundraising Background - The company has issued a total of 33.34 million shares at a price of RMB 32.21 per share, raising a total of RMB 1,073.88 million, with a net amount of RMB 974.05 million after deducting issuance costs [5]. Investment Method - The investment type includes large-denomination time deposits, with an investment amount of RMB 55 million [6]. Approval Process - The company held board and supervisory meetings on April 25, 2025, and a shareholder meeting on May 21, 2025, to approve the cash management proposal, allowing the use of idle raised funds for low-risk investment products [8]. Risk Analysis and Control Measures - The company acknowledges that while the investment products are of high safety and liquidity, they are still subject to market fluctuations [9]. - Risk control measures include strict adherence to prudent investment principles, careful selection of issuers, and ongoing monitoring of investment performance [10]. Previous Cash Management - The company has successfully redeemed previous cash management products, indicating a track record of managing idle funds effectively [12]. Impact on the Company - The cash management initiative will not affect the normal operation of the company's fundraising projects or its main business activities [13]. Sponsor's Opinion - The sponsor has expressed no objections to the cash management initiative, confirming that it complies with relevant laws and regulations and will not alter the intended use of raised funds [13].

证券代码：605566 证券简称：福莱蒽特 公告编号：2025-054 杭州福莱蒽特股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为提高资金使用效率，获取财务收益，为公司及股东获取更多的回报。 （二）现金管理金额 本次投资金额为人民币 5,500 万元。 （三）资金来源 根据中国证券监督管理委员会《关于核准杭州福莱蒽特股份有限公司首次公 开发行股票的批复》（证监许可[2021]3063 号），杭州福莱蒽特股份有限公司实 际已发行人民币普通股 3,334 万股，每股发行价格 32.21 元，募集资金总额为人 民币 1,073,881,400.00 元，减除发行费用人民币 99,830,686.78 元后，募集资金净 额为人民币 974,050,713.22 元。天健会计师事务所（特殊普通合伙）于 2021 年 了专户存储制度，设立了相关募集资金专项账户。募集资金到账后，已全部存放 于经公司董事会批准开设的募集资金专项账户内。 （四）投资方式 | ...

天眼查商业履历信息显示，杭州福莱蒽特股份有限公司，成立于1998年，位于杭州市，是一家以从事化 学原料和化学制品制造业为主的企业。企业注册资本13334万人民币，实缴资本13334万人民币。公司法 定代表人为李百春。 通过天眼查大数据分析，杭州福莱蒽特股份有限公司共对外投资了10家企业，参与招投标项目4次，知 识产权方面有商标信息27条，专利信息54条，此外企业还拥有行政许可23个。 来源：金融界 金融界消息 截至2025年7月31日收盘，福莱蒽特（605566）报收于23.92元，上涨0.89%，换手率 3.97%，成交量5.29万手，成交金额1.26亿元。 资金流向方面，今日主力资金净流入1688.51万元，占比成交额13.37%。其中，超大单净流入690.45万 元、占成交额5.47%，大单净流入998.05万元、占成交额7.9%，中单净流出流出947.18万元、占成交额 7.5%，小单净流出741.33万元、占成交额5.87%。 福莱蒽特最新一期业绩显示，截至2025一季报，公司营业总收入1.81亿元、同比减少17.57%，归属净利 润1372.54万元，同比减少9.13%，扣非净利润1289.77万 ...

证券代码：605566 证券简称：福莱蒽特 公告编号：2025-054 投资种类：单位大额存单 投资金额：人民币 5,500 万元 履行的审议程序：杭州福莱蒽特股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日召开第二届董事会第十次会议、第二届监事会第九次会议， 以及 2025 年 5 月 21 日召开 2024 年年度股东大会审议通过了《关于使用 部分闲置募集资金进行现金管理的议案》，同意公司在确保募投项目资金 需求和资金安全的前提下，使用最高额不超过人民币 86,000 万元的暂时 闲置募集资金进行现金管理，用于购买安全性高、流动性好的理财产品、 结构性存款及其他低风险投资产品。上述额度自 2024 年年度股东大会审 议通过之日起 12 个月内有效，单个理财产品或结构性存款的投资期限不 超过 12 个月，相关投资在上述额度及决议有效期内可以循环滚动使用。 保荐机构对上述事项发表了明确的同意意见。 特别风险提示：公司购买的是安全性高、流动性好、满足保本条件的单 位大额存单，但仍存在银行破产倒闭带来的清算风险、政策风险、流动性 风险、不可抗力风险等风险。 杭州福莱蒽特股份有限公司 关于使用部分 ...

Group 1 - The company announced the suspension of its subsidiary, Jiaxing New Materials, due to the harsh reality of overcapacity in the photovoltaic industry and challenges faced by traditional chemical companies entering the new energy sector [1][2] - The decision to suspend operations is aimed at aligning with the company's strategic direction and reducing operational costs, as Jiaxing New Materials has been experiencing poor sales and continuous losses [2][3] - The photovoltaic film industry faced significant challenges in 2024, with prices plummeting to historical lows, leading to a gross margin of -15.53% for the company's photovoltaic film business, which is significantly lower than the 19.95% gross margin of its dye business [3] Group 2 - The company's traditional dye business is also under pressure, with a revenue of 965 million yuan in 2024, a year-on-year increase of 5.3%, but a net profit of 22.02 million yuan, down 23.48% year-on-year, and a declining gross margin of 14.25% [4] - The company plans to evaluate the possibility of resuming operations at Jiaxing New Materials based on market conditions and is actively seeking external cooperation opportunities [5] - The high concentration in the photovoltaic film industry, with a CR4 of over 85% in 2022, suggests that the company's chances of re-entering this field may be low, while it is increasing R&D investment in environmentally friendly dyes and functional intermediates [5]

Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]

证券代码：605566 证券简称：福莱蒽特 公告编号：2025-053 杭州福莱蒽特股份有限公司 关于控股子公司停产歇业的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州福莱蒽特股份有限公司（以下简称"公司"）拟对控股子公司福莱蒽特 （嘉兴）新材料有限公司（以下简称"嘉兴新材料"）实行停产歇业，现将有关 情况公告如下： 2、住 所：浙江省嘉兴市海盐县西塘桥街道（海盐经济开发区）滨海大 道 1515 号 2 幢 3、法定代表人：李百春 4、注册资本：7,000 万人民币 5、成立日期：2023 年 7 月 24 日 6、经营范围：一般项目：新型膜材料制造；新型膜材料销售；合成材料制 造（不含危险化学品）；合成材料销售；高性能纤维及复合材料制造；高性能纤 维及复合材料销售；电子专用材料研发；电子专用材料制造；电子专用材料销售； 光伏设备及元器件制造；光伏设备及元器件销售；新材料技术研发；新材料技术 推广服务；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广； 太阳能发电技术服务；太阳能热发电产品销售；橡胶制品销 ...

Group 1 - The stock price of Fulei Ant (605566) closed at 20.4 yuan on July 16, 2025, down 1.16% with a turnover rate of 0.59% and a trading volume of 7,855 shares, amounting to a total transaction value of 16.15 million yuan [1] - On July 16, the capital flow for Fulei Ant showed a net outflow of 1.85 million yuan from main funds, accounting for 11.47% of the total transaction value, while retail investors had a net inflow of 516,500 yuan, representing 3.2% of the total transaction value [2][4] - Fulei Ant announced the signing of a tripartite supervision agreement for the storage of raised funds, confirming the issuance of 33.34 million ordinary shares at a price of 32.21 yuan per share, raising a total of 1,073.88 million yuan, with a net amount of 974.05 million yuan after deducting issuance costs [2][3] Group 2 - The tripartite supervision agreement stipulates that the raised funds will be stored in a special account specifically for the project of producing 3,000 tons of high-performance green disperse dye filter cake and 300 tons of key intermediate clean production technology improvement, with a maximum amount of 59.15 million yuan [3][4] - The agreement allows the sponsor, CITIC Securities, to continuously supervise the storage, management, and usage of the raised funds, with monthly account statements provided by the bank to both the company and the sponsor [3]

Fundraising Overview - The company has issued 33.34 million shares at a price of 32.21 RMB per share, raising a total of 1,073,881,400 RMB, with a net amount of 974,050,713.22 RMB after deducting issuance costs [1][2] Three-Party Supervision Agreement - The company signed a Three-Party Supervision Agreement with the sponsor CITIC Securities and Zhejiang Xiaoshan Rural Commercial Bank on July 16, 2025, to regulate the storage, use, and management of the raised funds [2][3] - The special account for the raised funds is designated for the project of producing 3,000 tons of high-fastness green disperse dye filter cake and 300 tons of key intermediates for clean production technology reform, with a maximum storage amount of 59.15 million RMB [2][3] Main Content of the Agreement - The agreement stipulates that the raised funds must not be used for non-designated purposes and outlines the procedures for cash management of temporarily idle funds [3][4] - The sponsor is responsible for continuous supervision of the fund management and usage, with the right to conduct on-site investigations and inquiries [4][5] - Monthly account statements must be provided by the bank to both the company and the sponsor [5][6] Compliance and Penalties - If the company withdraws more than 20% of the net amount of raised funds within 12 months, it must notify the sponsor within two working days [5][6] - The bank is liable for penalties if it fails to provide timely account statements or does not cooperate with the sponsor's investigations [6]

证券代码：605566 证券简称：福莱蒽特 公告编号：2025-052 杭州福莱蒽特股份有限公司 关于签订募集资金专户存储三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别连带责任。 一、募集资金基本情况 根据中国证券监督管理委员会《关于核准杭州福莱蒽特股份有限公司首次公开发行 股票的批复》（证监许可[2021]3063 号），杭州福莱蒽特股份有限公司（以下简称"公 司"）实际已发行人民币普通股 3,334 万股，每股发行价格 32.21 元，募集资金总额为 人民币 1,073,881,400.00 元，减除发行费用人民币 99,830,686.78 元后，募集资金净额 为人民币 974,050,713.22 元。天健会计师事务所（特殊普通合伙）于 2021 年 10 月 15 日出具了《验资报告》（天健验[2021]569 号）。公司对募集资金采取了专户存储制度， 设立了相关募集资金专项账户。募集资金到账后，已全部存放于经公司董事会批准开设 的募集资金专项账户内。 二、《募集资金专户存储三方监管协议》的签订情况和募 ...